Countries citing scholars working at China National Pharmaceutical Group Corporation (China)
Since Specialization
Citations
This map shows the geographic impact of research produced by authors working at China National Pharmaceutical Group Corporation (China). It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers produced at China National Pharmaceutical Group Corporation (China) with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites China National Pharmaceutical Group Corporation (China) more than expected).
Fields of papers published by authors at China National Pharmaceutical Group Corporation (China)
This network shows the impact of papers affiliated with China National Pharmaceutical Group Corporation (China) at the time of their publication. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers affiliated with China National Pharmaceutical Group Corporation (China) at the time of their publication.
About China National Pharmaceutical Group Corporation (China)
In recent decades, authors affiliated with China National Pharmaceutical Group Corporation (China) have published 855 papers, which have received a total of 14.6k indexed citations . Scholars at this organization have produced 44 papers in Complementary and alternative medicine, 40 papers in Pharmacology, 66 papers in Pharmacology, 66 papers in Infectious Diseases and 235 papers in Molecular Biology on the topics of SARS-CoV-2 and COVID-19 Research (30 papers), Traditional Chinese Medicine Analysis (28 papers), Viral gastroenteritis research and epidemiology (26 papers), Natural product bioactivities and synthesis (24 papers), Animal Virus Infections Studies (23 papers), Microbial Natural Products and Biosynthesis (22 papers), Virus-based gene therapy research (21 papers) and Advanced biosensing and bioanalysis techniques (21 papers). Their work is cited by papers focused on Infectious Diseases (2.6k citations), Pharmaceutical Science (431 citations), Complementary and alternative medicine (442 citations), Pharmacology (437 citations) and Pharmacology (761 citations). Authors at China National Pharmaceutical Group Corporation (China) collaborate with scholars in China, United States and Hong Kong and have published in prestigious journals including Scientific Reports, Frontiers in Pharmacology, Journal of Ethnopharmacology, Vaccine and RSC Advances. Some of China National Pharmaceutical Group Corporation (China)'s most productive authors include Aiping Lü, Fuchao Chen, Hua Zhang, Bing Zhu, Wenji Zhou, Liang‐Dong Guo, Yongsheng Che, Peng Chen, Benhong Zhou and Erwei Li.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.
Explore institutions with similar magnitude of impact